Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade.
Linpeng LiKeshi ChenTianyu WangYi WuGuangsuo XingMengqi ChenZhihong HaoCheng ZhangJin-Ye ZhangBochao MaZihuang LiuHao YuanZijian LiuQi LongYanshuang ZhouJuntao QiDanyun ZhaoMi GaoDuanqing PeiJinfu NieDan YeGuangjin PanXingguo LiuPublished in: Nature metabolism (2020)
Somatic cell reprogramming provides insight into basic principles of cell fate determination, which remain poorly understood. Here we show that the transcription factor Glis1 induces multi-level epigenetic and metabolic remodelling in stem cells that facilitates the induction of pluripotency. We find that Glis1 enables reprogramming of senescent cells into pluripotent cells and improves genome stability. During early phases of reprogramming, Glis1 directly binds to and opens chromatin at glycolytic genes, whereas it closes chromatin at somatic genes to upregulate glycolysis. Subsequently, higher glycolytic flux enhances cellular acetyl-CoA and lactate levels, thereby enhancing acetylation (H3K27Ac) and lactylation (H3K18la) at so-called 'second-wave' and pluripotency gene loci, opening them up to facilitate cellular reprogramming. Our work highlights Glis1 as a powerful reprogramming factor, and reveals an epigenome-metabolome-epigenome signalling cascade that involves the glycolysis-driven coordination of histone acetylation and lactylation in the context of cell fate determination.
Keyphrases
- dna methylation
- genome wide
- cell fate
- copy number
- gene expression
- induced apoptosis
- transcription factor
- stem cells
- cell cycle arrest
- genome wide identification
- endoplasmic reticulum stress
- cell therapy
- solid phase extraction
- single cell
- oxidative stress
- high resolution
- mesenchymal stem cells
- genome wide association